View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Therapeutics/Diagnostics News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 07, 2024
2 min read
Save

Linaclotide improves rate of bowel movements, consistency in children with constipation

Linaclotide improves rate of bowel movements, consistency in children with constipation

Treatment with once-daily linaclotide was well-tolerated and resulted in significant improvement in spontaneous bowel movements and stool consistency vs. placebo among children with functional constipation, researchers reported.

SPONSORED CONTENT
February 06, 2024
2 min read
Save

Infliximab levels above 6.9 mg/L at week 14 predict sustained remission in pediatric IBD

Infliximab levels above 6.9 mg/L at week 14 predict sustained remission in pediatric IBD

Infliximab concentrations above 6.9 mg/L at 14 weeks after initiation of treatment predicted sustained remission between 26 and 52 weeks in children with inflammatory bowel disease, according to researchers in the Netherlands.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
February 01, 2024
2 min read
Save

Prebiotic inulin causes ‘beneficial changes’ in microbiome of children with IBD

Prebiotic inulin causes ‘beneficial changes’ in microbiome of children with IBD

LAS VEGAS — Supplementation with prebiotic oligofructose-enriched inulin resulted in short-term microbiome changes as early as 4 weeks among children with inflammatory bowel disease, according to a presenter at Crohn’s & Colitis Congress.

SPONSORED CONTENT
January 30, 2024
2 min read
Save

Anti-TNF therapy significantly improves growth disturbances in pediatric Crohn’s

Anti-TNF therapy significantly improves growth disturbances in pediatric Crohn’s

LAS VEGAS — Although a substantial proportion of children with Crohn’s disease had growth disturbances at initiation of anti-tumor necrosis factor therapy, “significant improvement” was noted up to 24 months after treatment, data showed.

SPONSORED CONTENT
January 29, 2024
2 min read
Save

Dietitians have ‘very diverse, rich roles,’ add value to the IBD care team

Dietitians have ‘very diverse, rich roles,’ add value to the IBD care team

LAS VEGAS — Partnering with a dietitian who specializes in inflammatory bowel disease can augment patient care through nutritional assessment, dietary counseling and perioperative optimization, according to a presenter.

SPONSORED CONTENT
January 26, 2024
3 min read
Save

Growing armamentarium of therapies for IBD has ‘truly revolutionized’ care

Growing armamentarium of therapies for IBD has ‘truly revolutionized’ care

LAS VEGAS —A presenter at the Crohn’s & Colitis Congress outlined some of the newer therapies that have expanded the current “arsenal of tools” for the treatment of inflammatory bowel disease.

SPONSORED CONTENT
January 24, 2024
2 min read
Save

Q&A: Zymfentra ‘gives patients an option’ for at-home maintenance therapy of IBD

Q&A: Zymfentra ‘gives patients an option’ for at-home maintenance therapy of IBD

The FDA’s approval of Zymfentra in fall 2023 offers patients the “flexibility” of a subcutaneous therapy option for moderately to severely active ulcerative colitis and Crohn’s disease, Stephen B. Hanauer, MD, told Healio in an interview.

SPONSORED CONTENT
January 19, 2024
7 min watch
Save

VIDEO: ‘Dispel the myth of personal responsibility’ to combat obesity stigma

VIDEO: ‘Dispel the myth of personal responsibility’ to combat obesity stigma

In the latest installment of Healio’s diversity, equity and inclusion video series with the ASGE, Catherine T. Hudson, MD, addressed how to combat emerging stigma around new anti-obesity medications such as glucagon-like peptide agonists.

SPONSORED CONTENT
January 18, 2024
2 min read
Save

Glucose-lowering therapies linked to reduced risk for CV events in type 2 diabetes, MASLD

Glucose-lowering therapies linked to reduced risk for CV events in type 2 diabetes, MASLD

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists were associated with lower risk for cardiovascular events in type 2 diabetes, with or without metabolic dysfunction-associated steatotic liver disease.

SPONSORED CONTENT
January 08, 2024
2 min read
Save

Novel blood-sensing capsule ‘highly accurate’ in detecting upper GI bleeding

Novel blood-sensing capsule ‘highly accurate’ in detecting upper GI bleeding

The PillSense System, a novel blood-sensing swallowed capsule device, safely detected blood in patients with clinically suspected upper gastrointestinal bleeding with a sensitivity of 92.9% and a specificity of 90.6%, data showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails